FDAnews
www.fdanews.com/articles/61230-genentech-inotek-enter-into-alliance-on-cancer-drug

GENENTECH, INOTEK ENTER INTO ALLIANCE ON CANCER DRUG

July 27, 2006

Genentech, Inc., and Inotek Pharmaceuticals Corporation entered into an exclusive global collaboration to discover, develop, manufacture and commercialize inhibitors of poly (ADP-ribose) polymerase (PARP) for the potential treatment of cancer. PARP is a nuclear enzyme within cells that directs the repair of damaged DNA via the activation and recruitment of DNA repair enzymes and has applications for the treatment of oncology and cardiovascular conditions.

Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34411§ionid=)